Third Phase 3 Trial of Sativex, Cannabis Extract for MS Spasticity, Planned

Sep 17, 12:00 AM

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a phase 3 trial of Sativex, a cannabis extract, for MS spasticity.
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the column by Ed Tobias, MS Wire, “MS Paralympian Aims for a Bull’s-eye”.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.
Are you interested in learning more about multiple sclerosis? If so, please visit:
To join in on conversations regarding multiple sclerosis, please visit: